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RESEARCH ARTICLE
The Carcinogenic Liver Fluke Opisthorchis viverrini is a
Reservoir for Species of Helicobacter
Raksawan Deenonpoe1,2, Chariya Chomvarin3, Chawalit Pairojkul2, Yaowalux
Chamgramol2, Alex Loukas4, Paul J Brindley5, Banchob Sripa1,2*
Abstract
There has been a strong, positive correlation between opisthorchiasis-associated cholangiocarcinoma and
infection with Helicobacter. Here a rodent model of human infection with Opisthorchis viverrini was utilized to
further investigate relationships of apparent co-infections with O. viverrini and H. pylori. A total of 150 hamsters
were assigned to five groups: i) Control hamsters not infected with O. viverrini; ii) O. viverrini-infected hamsters;
iii) non-O. viverrini infected hamsters treated with antibiotics (ABx); iv) O. viverrini-infected hamsters treated
with ABx; and v) O. viverrini-infected hamsters treated both with ABx and praziquantel (PZQ). Stomach,
gallbladder, liver, colonic tissue, colorectal feces and O. viverrini worms were collected and the presence of
species of Helicobacter determined by PCR-based approaches. In addition, O. viverrini worms were cultured in
vitro with and without ABx for four weeks, after which the presence of Helicobacter spp. was determined. In situ
localization of H. pylori and Helicobacter-like species was performed using a combination of histochemistry and
immunohistochemistry. The prevalence of H. pylori infection in O. viverrini-infected hamsters was significantly
higher than that of O. viverrini-uninfected hamsters (p≤0.001). Interestingly, O. viverrini-infected hamsters treated
with ABx and PZQ (to remove the flukes) had a significantly lower frequency of H. pylori than either O. viverriniinfected hamsters treated only with ABx or O. viverrini-infected hamsters, respectively (p≤0.001). Quantitative
RT-PCR strongly confirmed the correlation between intensity H. pylori infection and the presence of liver fluke
infection. In vitro, H. pylori could be detected in the O. viverrini worms cultured with ABx over four weeks. In
situ localization revealed H. pylori and other Helicobacter-like bacteria in worm gut. The findings indicate that
the liver fluke O. viverrini in the biliary tree of the hamsters harbors H. pylori and Helicobacter-like bacteria.
Accordingly, the association between O. viverrini and H. pylori may be an obligatory mutualism.
Keywords: Opisthorchis viverrini - Helicobacter - H. pylori - reservoir host - hamster
Asian Pac J Cancer Prev, 16 (5), 1751-1758

Introduction
Cholangiocarcinoma (CCA) is highly prevalent in
Asian countries, particularly in Thailand, China, Taiwan
and Korea (Shin et al., 2010). The principal risk factor
for CCA in this region is infection with the human liver
flukes, Opisthorchis viverrini and Clonorchis sinensis,
which are Group 1 carcinogens as classified by the World
Health Organization (Sripa et al., 2007; 2012; Bouvard et
al., 2009; IARC, 2012). Thailand has the highest incidence
of CCA worldwide due to its robust association with
opisthorchiasis (Sripa and Pairojkul, 2008; Shin et al.,
2010). However, several other risk factors for this cancer
have been documented including primary sclerosing
cholangitis (see Rizvi and Gores, 2013), inflammatory
bowel disease (Huai et al., 2014), metabolic syndromes
(Wu et al., 2012), hepatitis virus (Matsumoto et al., 2014)

and infection with Helicobacter spp. (Zhou et al., 2013).
The latter has attracted increasing research interest in
recent years (Mateos-Munoz et al., 2013; Murphy et al.,
2014).
Helicobacter pylori infection was the first bacterial
infection known to be a causative factor of gastrointestinal
diseases including gastric adenocarcinoma (Bouvard et
al., 2009). Its virulence factors such as cagA and vacA are
involved in the pathogenesis of the diseases (Cid et al.,
2013; Hatakeyama, 2014). Other Helicobacter species,
specifically H. hepaticus and H. bilis also are implicated
in hepatobiliary disease (Zhou et al., 2013; MateosMuñoz et al., 2013; Murphy et al., 2014). We observed
an association between H. pylori and hepatolithiasis or
CCA in people in Northeast Thailand, a region endemic
for opisthorchiasis (Boonyanugomol et al., 2012b;
2012c). Molecular mechanisms integral to H. pylori
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induced hepatobiliary diseases have also been reported
(Boonyanugomol et al. 2011; 2012a). However, the
underlying mechanisms by which species of Helicobacter
associate with opisthorchiasis remain unclear. Here we
investigated the prospective inter-relationship between
infections with Helicobacter spp. and liver flukes in a
rodent model of this foodborne liver fluke infection.

Materials and Methods
Animals
Female Syrian hamsters, Mesocricetus auratus, about
8 weeks of age were housed in conventional conditions,
fed a commercial diet and given water ad libitum. Rodent
husbandry conformed to the ethical guidelines of the
Animal Laboratory Center, Faculty of Medicine, Khon
Kaen University; these studies were approved by the
Animal Ethics Committee of Khon Kaen University;
approval number AEKKU # 100/2555. Laboratory
infection of hamsters with O. viverrini was accomplished
by oral administration of 50 metacercariae, as described
(Lvova et al., 2012). Infected hamsters were maintained up
to three months after the infection; control, non-infected
hamsters were housed in identical conditions.
Experimental design
The hamsters (n=150) were assigned to five groups of
30 rodents each (Table 1): group 1 - uninfected controls
(n=30); group 2 - hamsters treated with antibiotics (ABx)
(clarithromycin 7.5 mg/kg BID+ metronidazole 20mg/
kg BID + amoxicillin 20 mg/kg BID), omeprazole 0.7
Table 1. Treatment Groups of Hamsters Infected with
the Liver Fluke Opisthorchis viverrini
Group
1
2
3
4
5

Number of
hamsters
30
30
30
30
30

Infection with
ABx
O. viverrini		

*ABx, antibiotics; PZQ, praziquantel

+
+
+

+
+
+

PZQ
+

mg/kg BID and sucralfate 300 mg/kg) twice a day for
14 days, as described (Khoshnegah et al., 2011); group
3 - O. viverrini infected hamsters; group 4 - O. viverriniinfected hamsters treated with ABx for 14 days; group
5 - O. viverrini-infected hamsters treated with ABx
for 14 days and then treated with praziquantel (PZQ)
(Biltricide, Bayer, Pittsburgh, PA) suspended in 2%
Cremophor EI (Sigma, St. Louis, MO) at 400mg/kg body
weight twice, with an interval of two weeks between
treatments aiming to eradicate the parasites. Hamsters
were euthanized, after which colorectal feces, stomach,
gallbladder, liver and worms were collected from each
group for DNA extraction. Some worms were cultured for
up to four weeks in RPMI 1640 medium supplemented
with penicillin and streptomycin. Samples of livers from
selected hamsters were fixed in 10% buffered formalin for
histochemistry and immunohistochemistry.
DNA extraction
One gram of stool sample was used for DNA extraction
using a QIAamp® DNA Stool Mini Kit (Qiagen, Germany).
The worms, liver, stomach, gallbladder and colon were
incubated with lysis buffer (10 mM Tris-HCl pH 8.5, 10
mM EDTA, 100 mM NaCl, 0.5% SDS), homogenized
with tissue grinder, and digested with proteinase K at
55°C overnight. Thereafter, DNAs were recovered using
precipitation with ethanol.
Molecular detection of Helicobacter species by PCR
Fifty ng DNA from each stool was used in the PCR
assay. The reaction mixture consisted of 1x GoTaq®
Colorless Master Mix (Promega, USA) containing 0.2 mM
dNTP, 1.5 mM MgCl2, primers at 0.2 mM and 1.25 U of
Taq DNA polymerase. Primer sequences for the detection
of Helicobacter spp. (16srRNA), H. pylori (ureA), H. bilis,
H. hepaticus are provided in Table 2. PCR was performed
in a GeneAmp® PCR system 9700 (Applied Biosystems,
Life Technologies) thermocycler. Amplified products
were sized by electrophoresis through 1.0% agarose,
stained with ethidium bromide and visualized under a
UV illuminator.

Table 2. Primer Sequences and PCR Conditions for the Detection of Species of Helicobacter
Genes

Primer sequences

PCR conditions

Product size (bp)

OF-ATTAGTGGCGCACGGGTGAGTAA 94oC 30 sec, 55oC 30 sec,
1,300
16Sr RNA
OR-TTTAGCATCCCGACTTAAGGC
72oC 1.5 min (35 cycles)		
(nested PCR)		
94oC 30 sec, 60oC 30 sec,		
IF-GAACCTTACCTAGGCTTGACATTG 72oC 30 sec (35 cycle
480
IR-GGTGAGTACAAGACCCGGGAA			
ureA
OF-GCTAATGGTAAATTAGTTCCTGG
94oC 30 sec, 62oC 30 sec,
411
(nested PCR) OR-CTCCTTAATTGTTTTTACATAGTTG 72oC 30 sec (40 cycles)		
		
94oC 30 sec, 59oC 30 sec,		
IF-AGTTCCTGGTGAGTTGTTCTTAA
72oC 30 sec (40 cycles)
350
IR-AACCACGCTCTTTAGCTCTGTC			
H. bilis
OF-CTATGACGGGTATCCGGC
98oC 10 sec, 55oC 30 sec,
718
OR-CTCACGACACGAGCTGAC
72oC 1 minute (35 cycles)		
IF- CAGAACTGCATTTGAAACTAC
98oC 15 sec, 57oC 30 sec,
418
IR-AAGCTCTGGCAAGCCAGC
72oC 30 sec (35 cycles)		
H. hepaticus OF-CTATGACGGGTATCCGGC
98oC 10 sec, 55oC 30 sec,
718
OR-CTCACGACACGAGCTGAC
72oC 1 minute (35 cycles)		
IF -GAAACTGTTACTCTG
98oC 15 sec, 56oC 30 sec,
405
IR-TCAAGCTCCCCGAAGGG
72oC 30 sec (35 cycles)		
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Quantitative real time PCR
H. pylori was quantified by real time PCR in all
stool DNA samples and worms from the five groups of
hamsters, as described (McDaniels et al., 2005; Linke et
al., 2010), with minor modifications. The H. pylori ureA
gene subunit ureA was targeted for real-time PCR, using
primers HpyF1: GGGTATTGAAGCGATGTTTCCT
and HpyR1: GCTTTTTTGC-CTTCGTTGATAGT. The
reaction mixture included 10 µl SYBR Green Master Mix
(Thermo Scientific, USA), 1.0 µl template DNA; 0.5 µl
of each primer (0.625 µM) and 9 µl nuclease-free water.
Thermocycling conditions using Roche’s Light Cycler
1.5 were: 9 min initial denaturation at 95°C, 40 cycles
of 15 s at 95°C and 60 s at 60°C for the annealing and
elongation steps. To quantify number of bacterial cells in
samples, a standard curve derived was established using
10-fold serial dilutions of H. pylori DNA from 108 cells/
ml. Cell numbers of H. pylori cell count in one gram of
colorectal feces was ascertained by the standard curve at
crossing point and log concentration, as described (Linke
et al., 2010). The cell concentration/amount of DNA
was calculated to obtain the same initial amount for all
templates. Escherichia coli was used as negative control.
In situ localization of H. pylori in O. viverrini flukes
Formalin-fixed and paraffin-embedded tissue sections
of O. viverrini infected hamster livers were histochemically
stained using the Warthin-Starry method (Hartman and
Owens, 2012). Briefly, sections were deparaffinized,
hydrated to water, rinsed in acidic distilled water pH
3.8-4.4, and stained with 1% silver nitrate solution
for 45 seconds in a microwave oven. After cooling to
room temperature, the slides were immersed in 0.15%
hydroquinone, 5% gelatin, 2% silver nitrate (reducing
solution) for one minute, rinsed thoroughly in tap water,
then dehydrated, cleared and mounted.
Specific localization of H. pylori was also undertaken
using an immunohistochemistry approach. In brief,
hydrated thin tissue sections were subjected to antigen
retrieval in 0.01 mol/l citrate buffer using a high
temperature pressure cooker; endogenous peroxidase
activity was blocked with 3% hydrogen peroxide in
methanol. Non-specific staining was minimized by
incubation in 5% normal horse serum in PBS. Sections
were probed with anti H. pylori rabbit polyclonal antibody
(Dako) overnight (primary antibody). After washing with
PBS, sections were incubated in biotinylated goat antirabbit IgG-HRP (Dako) for 60 min (secondary antibody),
washed and developed with 3,3’- diaminobenzidine (DAB)
(Sigma). Subsequently, sections were counterstained in
Mayer’s heamatoxylin, cleared, and mounted. Paraffinembedded gastric tissue from H. pylori-infected patient
was used as positive control. Negative control sections
were probed only with secondary antibody.
Statistical analyses
Chi-square (X2) or Fisher’s exact test was used to
compare the categorical data among treatment groups.
One-way ANOVA (Post Hoc test) was used to compare the
means of total cell counts per gram feces. p values≤0.05
were considered to be statistically significant.

Results
Prevalence of Helicobacter in hamster feces
Figure 1 presents the prevalence of infection with
species of Helicobacter as determined by fecal PCRs
targeting the 16S rRNA, ureA, H. bilis, and H. hepaticusspecific genes in O. viverrini-infected hamster with and
without treatments and controls. Baseline prevalence
of species of Helicobacter was significantly higher in
hamsters with O. viverrini infection (90%) than in non-O.
viverrini infected hamsters (43.3%) (p≤0.001). Similarly,
the prevalence of species of Helicobacter in the O.
viverrini infected group was significantly higher than both
the O. viverrini-infected group treated with ABx (46.7%)
and the O. viverrini-infected group treated with ABx and
PZQ (30%) (p≤0.05). Notably, the prevalence of H. pylori
infection (ureA gene positive) was significantly higher in
hamsters without O. viverrini infection (33.3%) than that
in non-O. viverrini infected hamsters treated with ABx
(16.7%) (p≤0.001).
Moreover, the prevalence of H. pylori in hamster
infected with O. viverrini (73.3%) was significantly higher
than in hamsters infected with O. viverrini and treated
with ABx (36.7%) and in those treated with both ABx and
PZQ (16.7%) (p≤0.001). Likewise, the prevalence of H.
bilis but not H. hepaticus infection was higher in the O.
viverrini infected hamsters (40%) than the non-O. viverrini
infected rodents (26.7%) (p≤0.001). In addition, H. bilis
infection was more prevalent in hamsters with O. viverrini
infection (26.7%) than in hamsters with O. viverrini
treated with ABx (13.3%) and the O. viverrini infected
group treated with ABx and PZQ (13.3%) (p≤0.05). Last,
and notable, the prevalence of H. pylori and H. bilis was
lower in hamsters infected with O. viverrini and treated
with ABx and PZQ than in O. viverrini-infected hamsters
treated only with ABx, and was similar to that in the
non-O. viverrini infected hamsters.
Prevalence of Helicobacter pylori in hamster organs
The prevalence of H. pylori in diverse hamster organsstomach, liver, colon, gallbladder including feces from
#
#

#

#

#

#
#

#

#

#

#
#

#

#

#

Figure 1. Prevalence of Helicobacter spp. Infection

in feces from 5 groups of hamsters. X-axis represents PCR
positivity (%) of Helicobacter 16SrRNA, UreA, H. bilis, and
H. hepaticus among groups. #Significant difference (p≤0.001)
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Figure 2. Prevalence of Helicobacter pylori Infection in
Various Hamster Organs by PCR. Data (%) for H. pylori
(p≤0.001) and *(p≤0.05)
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Figure 3. Quantification of Helicobacter pylori in
Colorectal Feces of Hamsters Using Quantitative RTPCR. Total bacterial cell counts among the following 5
groups of hamsters are compared; 1. Control (Group 1),
2. Control+ ABx (Group 2), 3. Infected hamster (Group
3), 4. Infected hamster + ABx (Group 4), and 5. Infected
hamster + ABx+ PZQ (Group 5). *Significant difference
among groups (p≤0.001)

colon, varied among the treatment groups (Figure 2). H.
pylori was more common (>70%) in colon and feces of O.
viverrini-infected compared to <40% in control hamsters
not infected with O. viverrini (p ≤ 0.001). After treatment
with ABx, the prevalence of H. pylori in both colon and
colorectal feces declined significantly. The prevalence of
H. pylori was significantly lower in O. viverrini-infected
hamsters treated with ABx and PZQ - 16.7% vs 66.7%
and 16.6% vs. 73.9% for the colon tissue and feces,
respectively (p≤0.001), levels about half those from the
ABx treated hamsters.
For the liver and gallbladder, in like fashion,
significantly higher prevalence of H. pylori was seen
in hamsters infected with O. viverrini compared to
non-infected controls (16.6% vs 6.7% and 18.0% vs
6.7%, respectively). Treatments with ABx and PZQ of
O. viverrini-infected hamsters significantly reduced the
prevalence of H. pylori to less than half of their ABx
baselines in both the liver and gallbladder (6.7% vs.
3.3% and 10.0% vs 3.3%, respectively). Similar to other
organs, infection prevalence of H. pylori in the stomach
was significantly higher in in O. viverrini infected (26.7%)
compared to uninfected hamsters (18.0%) (p≤0.05).
However, the prevalence of H. pylori in O. viverriniinfected hamsters treated with ABx and PZQ (13.3%) was
similar to those treated with ABx alone (13.3%), unlike
those organs/ tissues reported above. In overview, the
prevalence of H. pylori in organs of the ABx and PZQ
treated hamsters declined to about their ABx-treated
baselines.
Quantification H. pylori by quantitative real-time PCR
(qPCR)
Levels of H. pylori (H. pylori cell counts) in the five
groups of hamsters, as established from the qRT-PCR
standard curve, are presented in Figure 3. Significantly
divergent intensities of infection with H. pylori were

P=0.016

Figure 4. Quantification of Helicobacter pylori in O.
viverrini from Infected Hamsters (Group 2) and O.
viverrini from Infected Hamsters Treated with ABx
(Groupp 3). Data are representative of bacterial counts
from 5 worms/hamster recovered from each group
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Figure 5. Representative PCR Products Amplified by
using Helicobacter pylori Specific Primer (Product
Size=350 bp) from O. viverrini Worms (Recovered
from Group 2) Cultured with Antibiotics upto 4
Weeks, Excretory-secretory (ES) Products, Fresh
Worms and Ov metacercariae. M=Maker, N=Negative
control, Lane 1=Positive control (H. pylori), Lane 2=Fresh
Ov, Lane 3=Ov cultured 1 week, Lane 4=Ov cultured 2
weeks, Lane5=Ov cultured 3 weeks Lane6=Ov cultured
4 weeks, Lane7=ES products and Lane 8=Metacercariae,
respectively. Data are reprehensive of PCR products
amplified from DNA extracted from10 worms per
duration or DNA from 500 O. viverrini metacercariae.
Ov=Opisthorchis viverrini
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Figure 6. Identification of Helicobacter pylori in the O. viverrini Gut. (A) Cluster of H. pylori-like (short arrow) stained
with the Warthin-Starry method shown as dark brown curved rod-like bacteria in the lumen. (B) Specific detection of H. pylori with
anti-H. pylori antibody immunostained as a dark brown color (short arrow). Original magnification, x400

evident: O. viverrini-infected hamsters, 695,712±270,962
cells (mean ±SD/five worms); O. viverrini infected
hamsters treated with ABx, 297,033±167,158; O.
viverrini infected hamsters treated with ABX and PZQ,
86,763±86,585; uninfected hamsters, 52,105± 40,004;
and uninfected hamsters treated with ABx, 34,497±18,360
(p≤0.001). Overall, H. pylori infection intensity in O.
viverrini infected hamsters was significantly greater
than that of uninfected hamsters (p≤0.001). Of note,
O. viverrini infected hamsters treated with ABx and
PZQ showed significant reduction of H. pylori infection
intensity (p≤0.001), similar to levels detected in the
non-O. viverrini-infected hamsters treated or not treated
with ABx.
The quantification of H. pylori in O. viverrini worms
The H. pylori infection intensity in O. viverrini
recovered from hamsters (mean=13,806±6,162 cells/5
worms) was significantly greater than that in O. viverrini
from infected hamsters treated with ABx (9,951±3,220)
(Figure 4).
Detection of H. pylori in cultured O. viverrini worms
To investigate the presence of H. pylori in longterm culture with ABx, we did examine by PCR up to
4 weeks culture as well as in fresh worms, ES products
and metacercariae. The results showed that H. pylori
could be observed in fresh recovered adults, all cultured
worms, and ES products but not in the metacercariae of
O. viverrini (Figure 5).
In situ localization of H. pylori in O. viverrini
To directly investigate the existence/presence of H.
pylori in the O. viverrini flukes, in situ localization using
the Warthin-Starry technique and immunohistochemistry
was undertaken. Warthin-Starry staining revealed dark
brown curved rod-like structures that clearly resembled
H. pylori within the lumen of the gut of the flukes (Figure
6A). In like fashion, immunohistochemical staining with
antibody specific for H. pylori showed strong, positive
signals for the bacteria in the lumen of the gut of the
flukes (Figure 6B).

Discussion
Cholangiocarcinoma is highly prevalent in Asian
countries; particularly in Thailand (Shin et al., 2010)
and, besides dietary carcinogens, the main risk factor
is infection with the human liver flukes, O. viverrini
and Clonorchis sinensis (Sripa et al., 2007; Sripa and
Pairojkul, 2008; Petney et al., 2013; Sithithaworn et al.,
2014). Other risk factors associated with the infection such
as microbiota in the biliary system may also be involved
(Plieskatt et al., 2013). We recently found a significant
association between H. pylori or mixed H. pylori and H.
bilis but not H. hepaticus infection and CCA in patients
from Northeast Thailand, a region highly endemic for
opisthorchiasis (Boonyanugomol et al., 2012b; 2012c).
However, which species of Helicobacter associate with
opisthorchiasis, and why, remain unclear. We show here,
for the first time in a rodent model a human opisthorchiasis,
significantly higher prevalence of co-infection with H.
pylori and H. bilis but not H. hepaticus in O. viverriniinfected and uninfected hamsters. Interestingly, clearance
of the liver fluke infection following treatment with PZQ
significantly reduced the prevalence and intensity of H.
pylori in O. viverrini-infected hamsters suggested a strong
inter-relationship between the two pathogens. In addition,
in situ localization revealed H. pylori in the gut of the
worm and the presence of of H. pylori in worms cultured
with lengthy periods in antibiotics supports that adult O.
viverrini may act as a reservoir for H. pylori.
Species of Helicobacter including H. pylori, H.
hepaticus and H. bilis have been described from several
other mammals as well as from people (Fox et al., 1995;
Pellicano et al., 2008; Goldman et al., 2010). Fox et
al. (2009) reported hamsters naturally infected with H.
bilis and that aged animals showed chronic hepatitis,
hepatic dysplasia, fibrosis, and biliary hyperplasia.
During other liver fluke infections, H. bilis-like bacteria
has been identified in the intrahepatic bile ducts of
rats experimentally infected with Fasciola hepatica
(Foster, 1984). Our study reported a significant higher
prevalence of H. pylori and H. bilis but not H. hepaticus
in the colon feces of O. viverrini infected hamsters
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compared to uninfected hamsters both before and after
ABx treatment. We further investigated the source of
the higher fecal infection by examining the prevalence
of H. pylori in the stomach, liver, gallbladder, and colon
mucosa. Helicobacter spp. have been observed previously
in these sites (Fox et al., 1995). The findings presented
here demonstrated infection of liver and gallbladder with
H. pylori, and indicated that the H. pylori in these organs
originated from the liver fluke in the bile ducts rather than
from microbiome of the hamster stomach. The findings
indicated that infection with O. viverrini influenced the
higher positivity and intensity in the feces since levels
of H. pylori significantly declined following treatments
with ABx and PZQ (Figures 2 and Figure 3). The source
of Helicobacter infection of the liver and biliary system
may be ascending infection through the small intestine
(Pellicano et al., 2008). Partial bile duct obstruction
by the flukes as well as host inflammatory responses
cause bile stasis and facilitate ascending infection and
cholangitis (Carpenter, 1998; Sripa, 2003). We recently
reported higher number of bacterial species in O. viverrini
infected hamster bile and also colorectal feces (Plieskatt
et al., 2013). Although Helicobacter is bile-sensitive, the
mechanism by which colonization by this microbe of the
biliary system is accomplished is uncertain. It has been
suggested that the ‘acidification’ of bile through reflux
into the low pH of the stomach precipitates inhibitory bile
acids, thereby allowing colonization by H. pylori (Hynes et
al., 2003; Shao et al., 2008). In case of opisthorchiasis, the
infection by the flukes can disturb bile acid composition
(Wongpaitoon et al., 1988; Wonkchalee et al., 2012) that
may reduce alkalinity of the bile, leading to damage to
biliary epithelia and inflammation (Strazzabosco et al.
2000). All these phenomena may facilitate conditions
that favor colonization by Helicobacter during concurrent
infection with liver flukes.
Whether the presence of H. pylori in the biliary system
during opisthorchiasis occurs only in the bile and biliary
mucosa or also within the fluke had until now remained
unresolved. Here we demonstrated in situ localization of
H. pylori histochemically and immunohistochemically
in the gut or gastrodermal of the fluke. Accidental
contamination during specimen preparation cannot
account for these new findings since H. pylori was
qualitatively and quantitatively detected in the thoroughly
washed worms and cultured in the presence of ABx for
more than a month. However, the origin of infection of
the liver fluke with Helicobacter spp. is unclear. The fluke
likely ingests bile contents and biliary epithelium for
nutrition (Sripa, 2003; Sripa et al., 2007), and H. pylori is
likely ingested in the bile by the fluke. We postulate that H.
pylori can colonize and propagate in the gut epithelium of
O. viverrini and, in turn, continue to be released back into
bile with the excretions and secretions (ES) of the flukes.
DNA from H. pylori can be detected by PCR in the ES
products of the cultured worms (Figure 5). The epithelia
of the gut of O. viverrini may provide conditions favorable
to Helicobacter i.e. acidic to neutral pH, mucus as well
as specific adhesion molecules (Sachs et al, 2011; Dunne
et al., 2014). Together, these new findings suggest that O.
viverrini within the mammalian hepatobiliary system may
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be a reservoir of H. pylori.
The elevated prevalence of Helicobacter spp. in O.
viverrini-infected hamsters raises the question of whether
infection with Helicobacter contributes to pathogenesis
of hepatobiliary diseases as well as CCA. Hepatobiliary
diseases caused by species of Helicobacter in naturally
infected hamsters (Fox et al., 2009; Boonyanugomol
et al. 2012b; 2012c) are similar to those of O. viverrini
(Lvova et al., 2012; Mairiang et al., 2012). Indeed, the
chronic lesions ascribed to liver fluke infection in both
hamsters and humans, i.e., cholangitis, biliary hyperplasia
100.0
and metaplasia, and periductal fibrosis or even CCA may
be due, in part, to Helicobacter-associated hepatobiliary
disease. H. pylori and H. bilis DNA has been isolated
75.0
from liver tissue of humans with CCA and cholecystitis/
cholelithiasis from Thai patients living in regions endemic
for opisthorchiasis (Boonyanugomol et al. 2012b; 2012c).
Moreover, serological assays indicate active infection with50.0
H. pylori and H. bilis in Thais at high risk for CCA (Pisani
et al., 2008). H. bilis was also associated with biliary
cancers in two high-risk populations in Japan and Thailand
25.0
(Matsukura et al., 2002). The strong association between
liver fluke and H. pylori or H. bilis infection reported in
this study supports a role of these Helicobacter species in
the hepatobiliary diseases known during opisthorchiasis. 0
In conclusion, this study in a well-controlled hamster
model of infection revealed a significant relationship
between O. viverrini and Helicobacter spp., specifically H.
pylori and H. bilis. The in situ localization of H. pylori in
the gut of the fluke supports the hypothesis that O. viverrini
may be a reservoir of this carcinogenic bacterium. The
co-infection may orchestrate in the pathogenesis of liver
fluke-induced hepatobiliary diseases including CCA.
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